Market Overview

UPDATE: Wedbush Initiates Intuitive Surgical at Outperform on Market Leader Position

Share:
Related ISRG
The MedTech Group: 2017 Top Picks And Catalysts
Benzinga's Top Upgrades, Downgrades For January 4, 2017
Notable earnings after Tuesday's close (Seeking Alpha)

In a report published Tuesday, Wedbush analyst Tao Levy initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with an Outperform rating and $580.00 price target.

In the report, Wedbush noted, “Intuitive Surgical is the leader in the robotic surgery market with its da Vinci Surgical System, generating over $2 billion in revenues that we expect to grow at a 3-year CAGR of 16%. The company is highly profitable (operating profit margin of approximately 40%), with a pristine balance sheet that holds a net cash & investments position of $3+ billion ($75/share). While ISRG has encountered mounting criticisms from multiple parties, we find the risk/reward profile attractive at current levels. Our bullish outlook is predicated on the underpenetrated procedure opportunity, ongoing launch of new instruments and accessories, and ISRG's track record of innovation and new product development.”

Intuitive Surgical closed on Monday at $499.32.

Latest Ratings for ISRG

DateFirmActionFromTo
Jan 2017Evercore ISI GroupDowngradesBuyHold
Oct 2016Wells FargoInitiates Coverage OnOutperform
Aug 2016Raymond JamesInitiates Coverage onOutperform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Tao Levy WedbushAnalyst Color Initiation Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!